(Q31935428)

5 July 2017

1 reference

title

COX-2 inhibitors in rheumatoid arthritis (English)

1 reference

5 July 2017

0 references

Sundy JS

1

1 reference

5 July 2017

1 February 2001

1 reference

Current Rheumatology Reports

5 July 2017

1 reference

5 July 2017

3

1 reference

5 July 2017

1

1 reference

5 July 2017

86-91

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-001-0055-9

5 July 2017

0 references

cites work

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11926-001-0055-9

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-001-0055-9

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-001-0055-9

Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-001-0055-9

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

21 January 2018

1 reference

12 December 2020

Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques.

1 reference

12 December 2020

Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis

1 reference

12 December 2020

Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.

1 reference

12 December 2020

In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

1 reference

12 December 2020

COX-1-sparing NSAIDs--is the enthusiasm justified?

1 reference

12 December 2020

Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice

1 reference

12 December 2020

Are selective COX-2 inhibitors nephrotoxic?

1 reference

12 December 2020

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

1 reference

12 December 2020

Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations

1 reference

12 December 2020

Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis

1 reference

12 December 2020

Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.

1 reference

12 December 2020

Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

The regulatory control of non-steroidal anti-inflammatory agents

1 reference

12 December 2020

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage

1 reference

12 December 2020

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

1 reference

12 December 2020

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

12 December 2020

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 reference

12 December 2020

Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans

1 reference

12 December 2020

Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines

1 reference

12 December 2020

The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group

1 reference

12 December 2020

Four new anti-inflammatory drugs: responses and variations

1 reference

12 December 2020

Microdetermination of prostaglandin E2 in joint fluid in rheumatoid arthritis patients using gas chromatography/selected ion monitoring

1 reference

12 December 2020

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

12 December 2020

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction

1 reference

12 December 2020

Use of the Stoke Index to differentiate between disease-modifying agents and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

1 reference

12 December 2020

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

12 December 2020

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

1 reference

12 December 2020

Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs

1 reference

12 December 2020

Effects of nonsteroidal anti-inflammatory therapy on platelets

1 reference

12 December 2020

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

1 reference

12 December 2020

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

12 December 2020

Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective drug survival study

1 reference

12 December 2020

Immunologic tolerability profile of celecoxib

1 reference

12 December 2020

Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

12 December 2020

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value

1 reference

12 December 2020

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

12 December 2020

SALICYLATE THERAPY IN RHEUMATOID ARTHRITIS

1 reference

12 December 2020

Mechanism of action of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

10.1007/S11926-001-0055-9

Identifiers

DOI

1 reference

PubMed ID

11177775

Dimensions Publication ID

5 July 2017

0 references

1 reference

PubMed ID

11177775